PATENT CLAIM ANALYSIS

Application Number: 15966848
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "049000"]

Abstract:
Compositions and methods for the treatment of Charcot-Marie-Tooth disease and related disorders. Also provided are combination therapies for treating this disease by decreasing PMP22 expression in a subject.

Claim (Index 18):
The method of  claim 12 , wherein naltrexone or a salt thereof is administered orally in a unit dosage form at a daily dose of about 1 to about 20 mg.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12744962', '14269783', '12999125', '15212748', '15390972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7958216520585099
- 35 USC 102 Novelty (BERT): 0.5800667074178455
- Combined Prediction Score: 0.7742461575944435
- Mean Citation Score: 447.807256
- Max Citation Score: 542.01843
- Similarity Product: 379.5152102248512

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test